Chronic Myeloid Leukemia By Jorge Cortes, Michael Deininger
2006 | 176 Pages | ISBN: 0849379555 | PDF | 4 MB
2006 | 176 Pages | ISBN: 0849379555 | PDF | 4 MB
Chronic Myeloid Leukemia (CML) remains a key model for the improved understanding of the pathophysiology of a malignancy at a molecular level and has been used by researchers to develop a variety of therapies and therapeutic assessment methods. This concise, readable guide assembles and synthesizes the latest developments and trends in the treatment of CML and provides an authoritative and convenient summary of the latest progress in imatinib trials, the molecular monitoring of CML responses, and the engineering of new therapies to overcome resistance and improve patient care.